Natmed is proud to announce the release of the Second Edition of Natmed’s Medical Defence Review. This unique publication contains a review of case law and other developments in the medical malpractice industry and is an essential tool in keeping healthcare practitioners and healthcare facility operators up to date whilst also providing lessons and insights regarding any medico-legal related issues.
The first and second editions of Natmed’s Medical Defence Review, may be found at www.medicaldefence.mobi These publications are best used in conjunction with Natmed’s Glossary of Medico-Legal and Insurance Terms (Natmedipedia), Natmed’s What If? series and Natmed’s Annual Survey of Medical Malpractice Judgments of 2018.
The Medical Defence Review publications together with the Natmedipedia, Natmed’s ‘What If?’ series and Natmed’s Annual Survey of Medical Malpractice Judgments of 2018 (another industry first publication) are just some of Natmed’s contributions to the healthcare and insurance industries and form part of its support network provided exclusively to Natmed clients. To learn more about Natmed Medical Defence go to: www.medicaldefence.mobi
The deadly novel coronavirus outbreak (2019-CoV) has resulted in passenger and cargo ships being quarantined around the world, partial and complete travel bans to parts of China and shipping and airlines being ... Read More »
The claimant, suing the UK National Health Service, had a medical history of having undergone two caesarean sections and a tear to her womb. Her fourth pregnancy was therefore regarded as “high risk” ... Read More »
The debate around euthanasia and its legal implications has stirred again due to the recent case of Professor Sean Davison, charged with three counts of murder in circumstances where the deceased’s had asked ... Read More »
Professor Pieter Carstens
Insurance Gateway attended Norton Rose Fulbright’s Health Law Practice and Professor Pieter Carstens presentation on Wednesday, 29 January 2020. Where Professor Carstens ... Read More »
Insurance by which policyholders do not share in any surplus earnings distributed by the insurer. No policy dividends are payable. The premium is based on an estimate of future costs and investment earnings very close to what the insurer believes most likely will occur, with a slight margin added for contingencies and profit.